Health
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19 – GlobeNewswire
Initial agreement provides up to 40 million doses to COVAX in 2021First deliveries are expected to take place in Q1 2021 subject to the execution of supply…
- Initial agreement provides up to 40 million doses to COVAX in 2021
- First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility structure
- For the COVAX Advanced Market Commitment 92 countries, Pfizer and BioNTech will provide the vaccine to COVAX at a not-for-profit price
NEW YORK CITY, NY and MAINZ, GERMANY, January 22, 2021 (GLOBE NEWSWIRE) Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40…
Continue Reading
-
Noosa News22 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Business23 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General17 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News19 hours agoTips to improve engagement – Proctor